Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. NIEDERSAECHSISCHE BOERSE ZU HANNOVER
  5. Cannovum AG
  6. News
  7. Summary
    27N   DE000A2LQU21

CANNOVUM AG

(27N)
SummaryChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cannovum : expands cannabis wholesale license and enters the active ingredient market

09/28/2021 | 03:01am EDT

DGAP-News: Cannovum AG / Key word(s): Regulatory Approval
Cannovum AG expands cannabis wholesale license and enters the active ingredient market

28.09.2021 / 09:00
The issuer is solely responsible for the content of this announcement.


Cannovum AG (Düsseldorf, Munich, Hamburg, Berlin stock exchanges, gettex: ISIN DE000A2LQU21) is expanding its wholesale license through its subsidiary, Cannovum Health eG. The expansion includes the active ingredient license, which enables the trading of active pharmaceutical ingredients. Cannovum is now authorized to distribute dronabinol, the first cannabis-based active ingredient, to pharmacies.

Active pharmaceutical ingredients are the components of a medication that are responsible for its efficacy. They trigger the essential biochemical process that ensures the medication acts in a specific way in the human body. One of the most important active ingredients of cannabis is THC, which is considered to have the greatest pharmaceutical potential and therapeutic efficacy.

Cannovum's scientific sales force has undergone intensive training with medical professionals, including for the new THC active ingredients, to assist physicians and pharmacists with individual cannabis-based therapies.

With the active ingredient license, Cannovum can now deal with active pharmaceutical ingredients in general and is not limited to dronabinol. In addition, Cannovum already holds the pharmaceutical wholesale licenses, including the GMP license required to map manufacturing steps in Germany.

"We want to improve patient care and that's why we decided to add active substances to our portfolio. Active ingredients are the core element of every medication and indispensable in the effective therapy of patients. We want to give physicians the opportunity to find an effective individual treatment for each of their patients, because every patient deserves the best therapy," says Pia Marten, CEO of Cannovum AG.



28.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Cannovum AG
Rheinsberger Str. 76/77
10115 Berlin
Germany
Phone: +49 (0)30 3982 16360
E-mail: ir@cannovum.com
Internet: www.cannovum.com
ISIN: DE000A2LQU21
WKN: A2LQU2
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich
EQS News ID: 1236360

 
End of News DGAP News Service

1236360  28.09.2021 

fncls.ssp?fn=show_t_gif&application_id=1236360&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about CANNOVUM AG
09/28PRESS RELEASE : Cannovum AG expands cannabis wholesale license and enters the active ingre..
DJ
09/28CANNOVUM : expands cannabis wholesale license and enters the active ingredient market
EQ
09/08CANNOVUM : expands Supervisory Board and Medical Advisory Board
EQ
09/08PRESS RELEASE : Cannovum AG expands Supervisory Board and Medical Advisory Board
DJ
09/08Cannovum AG Has Appoints Priv. Doz. Dr. Med. Habil. Philipp Sewerin to the Supervisory ..
CI
09/06PRESS RELEASE : Cannovum AG starts European cannabis expansion with founding of Cannovum I..
DJ
09/06CANNOVUM : starts European cannabis expansion with founding of Cannovum Iberia LDA
EQ
09/06Cannovum AG Starts European Cannabis Expansion with Founding of Cannovum Iberia LDA
CI
06/29PRESS RELEASE : Cannovum AG enters the full-spectrum cannabis extract market
DJ
06/29CANNOVUM : enters the full-spectrum cannabis extract market
EQ
More news
Chart CANNOVUM AG
Duration : Period :
Cannovum AG Technical Analysis Chart | MarketScreener
Full-screen chart